A Multicenter, Randomized, Double-Blind Study to Evaluate the Safety and Efficacy of the Initial Therapy With Coadministration of Sitagliptin and Pioglitazone in Patients With Type 2 Diabetes Mellitus

Update Il y a 5 ans
Reference: EUCTR2006-005931-56

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Objective: After 24 weeks, to assess the effect of the coadministration of sitagliptin 100 mg q.d. and pioglitazone 30 mg q.d. compared to pioglitazone alone on HbA1c. Objective: To assess the safety and tolerability of the coadministration of sitagliptin 100 mg q.d. and pioglitazone 30 mg q.d.


Inclusion criteria

  • Type 2 diabetes mellitus